A £2,359,553 grant has been awarded by Innovate UK to The Pirbright Institute’s Dr Simon Graham to lead an international team developing an inexpensive, safe and effective vaccine to protect pigs against Nipah virus (NiV).
Pre-clinical diagnosis could be key to helping control the transmission of foot-and-mouth disease virus (FMDV) in the event of an outbreak, a new study from scientists at The Pirbright Institute and Wageningen Bioveterinary Research has concluded.
Newly discovered components of the chicken innate immune system suggest poultry may be better equipped to fight viruses than scientists previously thought.
Researchers from The Pirbright Institute investigating chicken immunology, have discovered a previously unknown interferon (antiviral molecule), which they identified as IFN Kappa (IFN-K). The chicken’s innate immune system is generally not well understood and Pirbright scientists have now used this new component to understand its particular function in helping chickens combat viruses.
The largest study of blood feeding by mosquitoes ever conducted in the UK, has revealed that some species are more selective than others when choosing a host. Researchers aimed to discover which birds and mammals mosquitoes were biting in order to understand the potential for the UK to experience outbreaks of vector-borne diseases.
Better coordinated vaccine strategies are urgently needed to combat the spread of peste des petits ruminants (PPR); a neglected but devastating livestock disease which now poses a threat to sheep and goat populations in Europe, say scientists from The Pirbright Institute.
Leading scientists at The Pirbright Institute have welcomed the confirmation of funding for its key scientific research programmes for the next five years from the Biotechnology and Biological Sciences Research Council (BBSRC), which was officially announced today.
Pirbright is an international centre of scientific excellence in the study of livestock diseases and is at the forefront of those organisations protecting the UK from the potentially devastating social and economic impact such diseases can have on the nation’s farming industry and food supply.
Dr. Bryan Charleston, has been appointed as Institute Director for The Pirbright Institute, a world-leading centre for the prevention and control of viral diseases of livestock, which receives strategic investment from the Biotechnology and Biological Sciences Research Council (BBSRC).
Scientists have made a breakthrough in the search for an effective vaccine for bovine respiratory syncytial virus (bRSV), which could also be effective against the human form of the disease that can be dangerous for infants and the elderly.
HRH The Princess Royal officially opened the BBSRC National Vaccinology Centre: The Jenner Building today (24 March, 2017) – a world leading vaccine development facility, located at The Pirbright Institute in Surrey.
The Pirbright Institute is to play a key role in a new international project funded by the European Commission, to fight the mosquito-transmitted diseases now threatening Europe.
The Infravec2 Project is an international consortium of 24 partner institutions coordinated by the Institut Pasteur, Paris.
® The Pirbright Institute 2020 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
